RICHARD I. STEINHART - Corporate Board Profile

TG THERAPEUTICS, INC.

Filing Date	Source Excerpt
2004-07-28	Richard I. Steinhart has been a director of the Company since July 2004. Since May 1992, Mr. Steinhart has been principal of Forest Street Capital, a boutique investment banking, venture capital, and management consulting firm. Prior to Forest Street Capital, from May 1991 to May 1992, he was the Vice President and Chief Financial Officer of Emisphere Technologies, Inc., a publicly held biopharmaceutical company that is working to develop and commercialize a proprietary oral drug delivery system. Prior to joining Emisphere Technologies, Mr. Steinhart spent seven years at CW Group, Inc., a venture capital firm focused on medical and healthcare investments, where he was a General Partner and Chief Financial Officer. Mr. Steinhart has previously served as a director of a number of privately-held companies, including ARRIS Pharmaceuticals, Inc., a biotechnology company involved with rational drug design; Membrex, Inc., a laboratory equipment manufacturing company; and, Photest, Inc., a diagnostics company. He began his career working as a certified public accountant and continues to be a New York State Certified Public Accountant. Mr. Steinhart holds a Bachelors of Business Administration and Masters of Business Administration from Pace University. Following the appointment of Messrs. Steinhart, Herskowitz, and Hoenlein to the Board of Directors in July 2004, the Board replaced each of the existing Audit Committee members with such individuals. The Board has determined that each of Messrs. Steinhart, Hoenlein and Herskowitz meet the independence and other requirements to serve on the Audit Committee under applicable securities laws and rules and listing standards of the American Stock Exchange. The Board created a Nominating Committee, comprised of Messrs. Herskowitz, Hoenlein, Steinhart and Tanen. The Compensation Committee is currently comprised of Messrs. Steinhart, Hoenlein, Herskowitz and Dr. Weiser.
2005-10-21	Richard I. Steinhart has been a director of the Company since July 2004. Since May 1992, Mr. Steinhart has been principal of Forest Street Capital, a boutique investment banking, venture capital, and management consulting firm. The Board appointed Messrs. Steinhart, Herskowitz, and Hoenlein to the Audit Committee to replace Messrs. Tanen and Kazam and Dr. Weiser. The Board created a Nominating Committee, comprised of Messrs. Herskowitz, Hoenlein, Steinhart and David M. Tanen, who resigned from the Board in September 2005. The Compensation Committee is currently comprised of Messrs. Steinhart, Hoenlein, Herskowitz and Dr. Weiser.
2006-11-17	Richard I. Steinhart has been a director of the Company since July 2004. Since April 2006, Mr. Steinhart has served as Chief Financial Officer of Electro-Optical Sciences, Inc., a publicly-held medical device company. From May 1992 to April 2006, Mr. Steinhart was principal of Forest Street Capital, a boutique investment banking, venture capital, and management consulting firm. Prior to Forest Street Capital, from May 1991 to May 1992, he was the Vice President and Chief Financial Officer of Emisphere Technologies, Inc., a publicly held biopharmaceutical company that is working to develop and commercialize a proprietary oral drug delivery system. Prior to joining Emisphere Technologies, Mr. Steinhart spent seven years at CW Group, Inc., a venture capital firm focused on medical and healthcare investments, where he was a General Partner and Chief Financial Officer. Mr. Steinhart has previously served as a director of a number of privately-held companies, including ARRIS Pharmaceuticals, Inc., a biotechnology company involved with rational drug design; Membrex, Inc., a laboratory equipment manu-facturing company; and, Photest, Inc., a diagnostics company. He began his career working as a certified public accountant and continues to be a New York State Certified Public Accountant. Mr. Steinhart holds a Bachelors of Business Administration and Masters of Business Administration from Pace University.
2007-04-30	Richard I. Steinhart has been a director of the Company since July 2004. ... The Board of Directors has three standing committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. The following table provides membership for each of the Board committees: Audit Committee Messrs. Herskowitz, Hoenlein and Steinhart (Chair) Compensation Committee Messrs. Herskowitz, Hoenlein, Steinhart and Dr. Weiser Nominating and Governance Committee Messrs. Herskowitz, Hoenlein and Steinhart ... The following table shows the compensation earned by each of our non-employee directors for the year ended December 31, 2006: Richard I. Steinhart Fees Earned or Paid in Cash $4,000 Option Awards $32,022 All Other Compensation $0 Total $36,022
2008-05-12	Richard I. Steinhart has been a director of the Company since July 2004. ... Audit Committee members: Messrs. Herskowitz, Hoenlein and Steinhart (Chair). ... Compensation Committee members: Messrs. Herskowitz, Hoenlein, Steinhart and Weiser (Chair). ... Nominating and Governance Committee members: Messrs. Herskowitz, Hoenlein and Steinhart (Chair). ... The following table shows the compensation earned by each of our non-employee directors for the year ended December 31, 2007: Richard I. Steinhart total compensation $34,948.
2009-10-29	Richard I. Steinhart has been a director of Manhattan since July 2004. Since April 2006, Mr. Steinhart has served as Chief Financial Officer of Electro-Optical Sciences, Inc., a publicly-held medical device company. ... The following table shows the compensation earned by each of our non-employee directors for the year ended December 31, 2008: Richard Steinhart (5) $6,500 $14,767 - $21,267 ... Audit Committee: Messrs. Herskowitz and Steinhart (Chair) ... Compensation Committee: Messrs. McInerney, Steinhart and Dr. Weiser (Chair) ... Nominating and Governance: Messrs. Herskowitz, Hoenlein and Steinhart (Chair)
2011-03-22	Richard I. Steinhart has been a director of Manhattan since July 2004. ... Audit Committee members: Messrs. Herskowitz, Shimko and Steinhart (Chair). ... Compensation Committee members: Messrs. McInerney, Steinhart and Herskowitz (Chair). ... Nominating and Governance Committee members: Messrs. Herskowitz, Shimko and Steinhart (Chair). ... The following table shows the compensation earned by each of our non-employee directors for the year ended December 31, 2008: Richard Steinhart $32,855 total compensation.